A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Human medicines European public assessment report (EPAR): Xtandi, enzalutamide, Prostatic Neoplasms, Date of authorisation: 21/06/2013, Date of refusal: 26/04/2013, Revision: 14, Status: Authorised
Case Medical Research
Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contactdoi:10.31525/cmr-9a26f7 fatcat:vrkcw3ov6fcabhreuxmcprg75u